| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $6.0M | — |
| SG&A Expense | $5.8M | +135.9% |
| Operating Income | -$39.3M | -91.6% |
| Income Tax | $0 | — |
| Net Income | -$36.9M | -68.4% |
| EPS (Basic) | -$2.52 | -8.5% |
| EPS (Diluted) | -$2.52 | -8.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.4M | -47.2% |
| Current Assets | $56.7M | -41.7% |
| Total Assets | $446.5M | +24.5% |
| Current Liabilities | $36.6M | +30.7% |
| Total Liabilities | $57.0M | +11.9% |
| Stockholders' Equity | $287.7M | +9.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.6M | -160.0% |
| Investing Cash Flow | -$98.8M | -49.4% |
| Financing Cash Flow | $101.1M | -31.0% |